Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant human erythropoietin (rHuEPO) |
---|---|
Date Designated: | 05/26/2011 |
Orphan Designation: | Treatment of mutliple myeloma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
XTL Biopharmaceuticals, Ltd 85 Medinat Hayehudim St. Herzliya Pituach 46766 Israel The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-